Breakthrough Therapy Designation granted to treatment for IDLs
Ofev, which is under review for the treatment of people…
Ofev, which is under review for the treatment of people with chronic fibrosing interstitial lung diseases (ILDs), has been given Breakthrough Therapy Designation.